Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces post-meal glucose excursion in patients with type 2 diabetes by a non-renal mechanism: results of a randomized trial
Stein, Peter, Berg, Jolene K., Morrow, Linda, Polidori, David, Artis, Eunice, Rusch, Sarah, Vaccaro, Nicole, Devineni, DamayanthiVolume:
63
Language:
english
Journal:
Metabolism
DOI:
10.1016/j.metabol.2014.07.003
Date:
October, 2014
File:
PDF, 563 KB
english, 2014